This is also in line with the ccRCC development model previously proposed by Brugarolas et al. The mutation of VHL is the initial event and the subsequent mutations of PBRM1 and SETD2 may contribute to transformation, while the mutation of BAP1 confers greater aggressiveness (55). The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.